Cargando…

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside

Background: Trastuzumab, a humanized anti-human epidermal growth factor receptor 2 (HER2/neu) antibody, is considered a standard treatment in addition to chemotherapy in the adjuvant setting for HER2/neu-positive breast cancer, yet its impact on fertility and ovarian reserve remains obscure. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levi, Mattan, Goshen-Lago, Tal, Yerushalmi, Rinat, Granot, Tal, Stemmer, Salomon M., Shalgi, Ruth, Ben-Aharon, Irit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762209/ https://www.ncbi.nlm.nih.gov/pubmed/33297351 http://dx.doi.org/10.3390/biomedicines8120577

Ejemplares similares

Cancer During Pregnancy: The Role of Vascular Toxicity in Chemotherapy-Induced Placental Toxicity
por: Bar-Joseph, Hadas, et al.
Publicado: (2020)

Treosulfan induces distinctive gonadal toxicity compared with busulfan
por: Levi, Mattan, et al.
Publicado: (2018)

Pretreatment with gonadotropin-releasing hormone antagonist protects against chemotherapy-induced testicular damage ‘in mice
por: Levi, Mattan, et al.
Publicado: (2022)

Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity
por: Ben Aharon, Irit, et al.
Publicado: (2013)

Premature ovarian aging in BRCA carriers: a prototype of systemic precocious aging?
por: Ben-Aharon, Irit, et al.
Publicado: (2018)

Irinotecan (CPT-11) Treatment Induces Mild Gonadotoxicity
por: Levi, Mattan, et al.
Publicado: (2022)

Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma
por: Haddad, Riad, et al.
Publicado: (2022)

miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines
por: Ninio-Many, Lihi, et al.
Publicado: (2020)

Doxorubicin-induced ovarian toxicity
por: Ben-Aharon, Irit, et al.
Publicado: (2010)

Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 &12 in Breast Cancer Patients: A Retrospective Analysis
por: Yerushalmi, Rinat, et al.
Publicado: (2014)

MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells
por: Ninio-Many, Lihi, et al.
Publicado: (2014)

Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
por: Landman, Yosef, et al.
Publicado: (2019)

In vivo Bioimaging as a Novel Strategy to Detect Doxorubicin-Induced Damage to Gonadal Blood Vessels
por: Bar-Joseph, Hadas, et al.
Publicado: (2011)

Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
por: Ben-Aharon, Irit, et al.
Publicado: (2013)

Young patients with cancer and a digital social network: the voice beyond the clinic
por: Ben-Aharon, Irit, et al.
Publicado: (2020)

HER3 in cancer: from the bench to the bedside
por: Gandullo-Sánchez, Lucía, et al.
Publicado: (2022)

Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer
por: Zlotnik, Oran, et al.
Publicado: (2021)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
por: Mutai, Raz, et al.
Publicado: (2021)

Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
por: Michal, Sternschuss, et al.
Publicado: (2021)

Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022)

Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
por: Granot, Tal, et al.
Publicado: (2016)

Dendritic Cell Cancer Vaccines: From the Bench to the Bedside
por: Katz, Tamar, et al.
Publicado: (2014)

The Potential Role of Immune Alteration in the Cancer–COVID19 Equation—A Prospective Longitudinal Study
por: Goshen-Lago, Tal, et al.
Publicado: (2020)

Psychosocial perspectives among cancer patients during the coronavirus disease 2019 (COVID‐19) crisis: An observational longitudinal study
por: Turgeman, Ilit, et al.
Publicado: (2021)

Bench and Bedside
por: Schmidt, Christian
Publicado: (2002)

Bench-to-bedside review: Mechanisms and management of hyperthermia due to toxicity
por: Eyer, Florian, et al.
Publicado: (2007)

Bench to Bedside: Animal Models of Radiation Induced Musculoskeletal Toxicity
por: Farris, Michael K., et al.
Publicado: (2020)

From bench to bedside
por: Verdant, Colin L
Publicado: (2012)

Coronary atherosclerosis and chemotherapy: From bench to bedside
por: Zhou, Fanghui, et al.
Publicado: (2023)

Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
por: Goshen-Lago, Tal, et al.
Publicado: (2021)

Regulation of GVBD in mouse oocytes by miR-125a-3p and Fyn kinase through modulation of actin filaments
por: Grossman, Hadas, et al.
Publicado: (2017)

Sepsis: From Bench to Bedside
por: Silva, Eliézer, et al.
Publicado: (2008)

Sonochemotherapy: from bench to bedside
por: Lammertink, Bart H. A., et al.
Publicado: (2015)

Nutrition: From Bench to Bedside
por: Khan, Naim A., et al.
Publicado: (2016)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Pruritus: From the Bench to the Bedside
por: Reich, Adam, et al.
Publicado: (2018)

Silver linings at the bench and bedside
por: Katz, Steven C., et al.
Publicado: (2020)

Olutasidenib: from bench to bedside
por: Venugopal, Sangeetha, et al.
Publicado: (2023)

Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012)

Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_r0l5dv9s83r7vcgltrog4kd6pq